elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33869257-D7E73FF4-179C-4C1F-BB1A-9EA06A6839E7
Q33869257-D7E73FF4-179C-4C1F-BB1A-9EA06A6839E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33869257-D7E73FF4-179C-4C1F-BB1A-9EA06A6839E7
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.
P2860
Q33869257-D7E73FF4-179C-4C1F-BB1A-9EA06A6839E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33869257-D7E73FF4-179C-4C1F-BB1A-9EA06A6839E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c81f6270dcb357e099eeaeb655cfba7bec2183c0
P2860
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors